Cargando…
Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
Tumor necrosis factor (TNF) and interleukin-1 receptor antagonist (IL-1Ra) are key players in stroke, a disease in which cell-based therapies have shown great potential. Having shown an infarct-reducing effect of bone marrow (BM) cells, especially cells with high IL-1Ra expression, we here investiga...
Autores principales: | von Linstow, Christian Ulrich, Hindkjær, Sofie Mozart, Nielsen, Pernille Vinther, Degn, Matilda, Lambertsen, Kate Lykke, Finsen, Bente, Clausen, Bettina Hjelm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074385/ https://www.ncbi.nlm.nih.gov/pubmed/33924148 http://dx.doi.org/10.3390/cells10040956 |
Ejemplares similares
-
Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
por: Clausen, Bettina Hjelm, et al.
Publicado: (2016) -
Post-stroke inflammation—target or tool for therapy?
por: Lambertsen, Kate Lykke, et al.
Publicado: (2018) -
Selective Inhibition of Soluble Tumor Necrosis Factor Alters the Neuroinflammatory Response following Moderate Spinal Cord Injury in Mice
por: Lund, Minna Christiansen, et al.
Publicado: (2023) -
The Inflammatory Response after Moderate Contusion Spinal Cord Injury: A Time Study
por: Lund, Minna Christiansen, et al.
Publicado: (2022) -
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
por: Clausen, Bettina Hjelm, et al.
Publicado: (2014)